Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).

Eligibility criteria

Qualifiers

Adults ≥ 18 years

VV-ECMO initiated during or after emergency thoracic surgery

No opposition to data use

Disqualifiers

Pregnant women

Veno-Arterial ECMO patients

Patients under legal protection

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

380 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Centre Hospitalier Universitaire Dijon

Collaborator